Aragen Life Sciences vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aragen/oncodesign-services

Category	Aragen Life Sciences	Oncodesign Services
Listed site	cro	cro
Summary	Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.	Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs	Discovery Research Target Identification & Validation Medicinal Chemistry In Vitro Pharmacology In Vitro ADME / DMPK In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Specialized & Large-Animal Models Bioanalysis Immunogenicity Assays (ADA / NAb) Biomarker Assays Clinical Imaging Core Lab Oncology Specialty Services Immunology & Inflammation Services Virology Services GLP Toxicology Safety Pharmacology Translational Research Preclinical In Vitro Studies Regulatory Affairs LC-MS Bioanalysis (Small Molecule) High-Throughput Screening Genetic Toxicology Computational & In-Silico Drug Discovery Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Ligand-Binding Bioanalysis (Large Molecule)
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Oligonucleotide mRNA Cell Therapy Gene Therapy Peptide Vaccine	Small Molecule Biologics (Other) Antibody-Drug Conjugate (ADC) Radiopharmaceutical
Indications	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health	Oncology Immunology Infectious Disease Dermatology Gastroenterology Nephrology Metabolic Rare Disease Respiratory
Locations	Global Headquarters, Hyderabad, Telangana, India R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Hyderabad, Telangana, India Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India R&D Campus, Bengaluru, Karnataka, India Biosafety Solutions, Pune, Maharashtra, India Regional Office, New Delhi, Delhi, India Sales Office, Tokyo, Japan Sales Office, Seoul, South Korea Sales Office, Cambridge, Massachusetts, USA R&D Campus, Morgan Hill, California, USA Sales Office, Utrecht, Netherlands Sales Office, Milan, Italy Sales Office, South Korea Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Pune, Maharashtra, India R&D Campus, New Delhi, Delhi, India Sales Office, New Jersey, New Jersey, USA Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Mallapur, Hyderabad, India	Headquarters, Dijon, Bourgogne-Franche-Comté, France Headquarters
Certifications	USFDA · Identifier: EIR for Nacharam Unit 1	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.